Short-term effect of a new oral sodium hyaluronate formulation on knee osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial
Cicero AFG, Girolimetto N, Bentivenga C, Grandi E, Fogacci F, Borghi C
Published in Diseases
Methodology
Randomised double-blind placebo-controlled trial of an oral sodium hyaluronate formulation in adults with symptomatic knee osteoarthritis over 8 weeks
Key Findings
Oral sodium hyaluronate significantly reduced WOMAC pain and improved function compared with placebo, with good tolerability.
Conclusions
Oral hyaluronate produced short-term symptomatic relief in knee osteoarthritis.
Limitations
Short follow-up; single centre; small sample.
Supplements Studied
Oral sodium hyaluronate significantly reduced WOMAC pain and improved function compared with placebo.
Outcomes Measured
Oral sodium hyaluronate significantly reduced WOMAC pain and improved function.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.